ShareValue scores for 0455.HK: Valuation 61, Quality 26, Growth 62, Health 39.

0455.HK
HKEX

Tianda Pharmaceuticals Ltd

HK$0.10(+1.96%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

3% to 19%
Valuation
61
Fair Value
Price vs Value
Quality
26
Weak
Business Strength
Growth
62
Moderate
Revenue & Earnings
Health
39
Stressed
Financial Stability
Momentum
63
Bullish
Price Trend

Company Details

About

Tianda Pharmaceuticals Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia. It operates through the Chinese Medicine; Pharmaceuticals and Medical Technologies; and Medical and Healthcare Services segments. The company offers Chinese herbal medicine, Chinese medicine decoction pieces, Chinese medicine products, and Chinese medicine clinical services. It also produces pharmaceutical products focusing on cardiovascular and cerebrovascular medication, respiratory infections, and pediatric diseases. In addition, the company trades agricultural by-products. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. The company was incorporated in 1992 and is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.

Score Analysis

AI Investment Thesis

Data as of:Jul 31, 2026
|
Last calculated:Jul 31, 2026